| Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3 M de Las Rivas, EJ Paul Daniel, Y Narimatsu, I Compañón, K Kato, ... Nature chemical biology 16 (3), 351-360, 2020 | 59 | 2020 |
| The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences M de Las Rivas, E Lira-Navarrete, EJP Daniel, I Compañón, H Coelho, ... Nature communications 8 (1), 1959, 2017 | 41 | 2017 |
| Structural and mechanistic insights into the catalytic-domain-mediated short-range glycosylation preferences of GalNAc-T4 M de Las Rivas, EJ Paul Daniel, H Coelho, E Lira-Navarrete, L Raich, ... ACS Central Science 4 (9), 1274-1290, 2018 | 38 | 2018 |
| Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation EJP Daniel, M Las Rivas, E Lira-Navarrete, A García-García, ... Glycobiology 30 (11), 910-922, 2020 | 27 | 2020 |
| The structure of the colorectal cancer-associated enzyme GalNAc-T12 reveals how nonconserved residues dictate its function AJ Fernandez, EJP Daniel, SP Mahajan, JJ Gray, TA Gerken, LA Tabak, ... Proceedings of the National Academy of Sciences 116 (41), 20404-20410, 2019 | 20 | 2019 |
| ALG13 X‐linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes H Alsharhan, M He, AC Edmondson, EJP Daniel, J Chen, T Donald, ... Journal of inherited metabolic disease 44 (4), 1001-1012, 2021 | 11 | 2021 |
| Differential splicing of the lectin domain of an O-glycosyltransferase modulates both peptide and glycopeptide preferences C May, S Ji, ZA Syed, L Revoredo, EJP Daniel, TA Gerken, LA Tabak, ... Journal of Biological Chemistry 295 (35), 12525-12536, 2020 | 8 | 2020 |
| Expanding the phenotype, genotype and biochemical knowledge of ALG3‐CDG H Alsharhan, BG Ng, EJP Daniel, J Friedman, EK Pivnick, A Al‐Hashem, ... Journal of inherited metabolic disease 44 (4), 987-1000, 2021 | 7 | 2021 |
| Fractionated plasma N‐glycan profiling of novel cohort of ATP6AP1‐CDG subjects identifies phenotypic association H Alharbi, EJP Daniel, J Thies, I Chang, DL Goldner, BG Ng, P Witters, ... Journal of inherited metabolic disease 46 (2), 300-312, 2023 | 6 | 2023 |
| ALG8‐CDG: Molecular and phenotypic expansion suggests clinical management guidelines D Albokhari, BG Ng, A Guberinic, EJP Daniel, NM Engelhardt, R Barone, ... Journal of inherited metabolic disease 45 (5), 969-980, 2022 | 6 | 2022 |
| ALG1-CDG caused by non-functional alternative splicing involving a novel pathogenic complex allele CA González-Domínguez, MO Fiesco-Roa, S Gómez-Carmona, ... Frontiers in Genetics 12, 744884, 2021 | 6 | 2021 |
| DDOST‐CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype I Elsharkawi, P Wongkittichote, EJP Daniel, RT Starosta, K Ueda, BG Ng, ... Journal of inherited metabolic disease 46 (1), 92-100, 2023 | 3 | 2023 |
| Homozygous truncating variant in MAN2A2 causes a novel congenital disorder of glycosylation with neurological involvement FHH 6. Mahajan S, Ng BG, AlAbdi L, Paul Daniel E, Sosicka P, Patel N, Helaby ... J Med Genet, 2022 | 2* | 2022 |
| Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation CJ Ballard, MR Paserba, EJ Paul Daniel, R Hurtado-Guerrero, TA Gerken Glycobiology 33 (10), 817-836, 2023 | 1 | 2023 |
| D-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG) RT Starosta, AJ Lee, ER Toolan, M He, P Wongkittichote, EJP Daniel, ... Molecular Genetics and Metabolism, 108488, 2024 | | 2024 |
| Case report: Novel genotype of ALG2-CDG and confirmation of the heptasaccharide glycan (NeuAc-Gal-GlcNAc-Man2-GlcNAc2) as a specific diagnostic biomarker I Martínez Duncker, D Mata-Salgado, I Shammas, W Ranatunga, ... Frontiers in Genetics 15, 1363558, 2024 | | 2024 |
| Deficient glycan extension and endoplasmic reticulum stresses in ALG3‐CDG EJP Daniel, AC Edmondson, Y Argon, H Alsharhan, C Lam, HH Freeze, ... Journal of Inherited Metabolic Disease, 2024 | | 2024 |
| GalNAc-T isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation. CJ Ballard, MR Paserba, EJP Daniel, R Hurtado-Guerrero, TA Gerken Glycobiology, cwad066-cwad066, 2023 | | 2023 |
| O05: Fractionated plasma N-glycan analysis identifies sensitive diagnostic biomarkers for congenital disorders of glycosylation (CDG) EJP Daniel, A Edmondson, E Morava-Kozicz, HH Freeze, M He Genetics in Medicine Open 1 (1), 2023 | | 2023 |
| Peptide Substrate Charge Distributions: A New Hallmark Governing GalNAc-T Specificity C Ballard, M Paserba, D Nguyen, K Moore, EJP Daniel, M Viazmitinas, ... GLYCOBIOLOGY 32 (11), 973-973, 2022 | | 2022 |
